Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at Highway 14 and Silver Queen Road


Car, Truck Catch Fire in Fatal Mojave Accident 

Fatal Accident 6

Mojave, CA (February 25, 2020) – One person was killed in a crash in Mojave. The fatal accident occurred on the evening of February 25 at Highway 14 and Silver Queen Road.

A car and a truck collided in the southbound lanes of the road. Both vehicles caught fire. One person died at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Mojave

#93501


May 1, 2020

Motorcyclist Injured in Crash at West Florence Avenue and South Flower Street

Motorcycle, SUV Collide in Los Angeles Accident...


November 20, 2019

Amanda Dyball Injured in Pedestrian Crash on Highway 101

Victim Hit by Car in Eureka Accident...


April 27, 2020

Motorcyclist Killed in Crash on Highway 62 Near Pierson Boulevard

Motorcycle, Passenger Vehicle Collide in Fatal Desert Hot Springs Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.